FIELD: medicine, pharmacy. SUBSTANCE: invention proposes an antiemetic agent representing benzamide (benzoic acid amide). Benzamide exhibits the less expressed toxicity as compared with that of ondansetron hydrochloride. EFFECT: expanded assortment of agents of indicated designation. 2 cl, 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION CONTAINING ONDANSETRON AND BENZAMIDE | 2003 |
|
RU2228752C1 |
| PHARMACEUTICAL COMPOSITION CONTAINING ONDANSETRON AND METHACINE | 2001 |
|
RU2185825C1 |
| PHARMACEUTICAL COMPOSITION COMPRISING ONDANSETRON, METHACINE AND BENZAMIDE | 2003 |
|
RU2234315C1 |
| AGENT DIMINISHING TOXICITY OF ANTI-TUMOR PREPARATIONS | 2003 |
|
RU2236848C1 |
| PHARMACEUTICAL COMPOSITION FOR REDUCTION OF PRIMARY RADIATION RESPONSE AND EARLY TRANSIENT INCAPABILITY | 2012 |
|
RU2509557C1 |
| COMBINED COMPOSITION OF SUBSTANCES WITH COMPLEX PHARMACOLOGICAL ACTIVITY | 2014 |
|
RU2622991C2 |
| MEDICINAL AGENT | 2007 |
|
RU2363463C1 |
| ANTI-TUMOR AGENT BENZAMIDE | 2003 |
|
RU2257894C1 |
| METHOD FOR PREVENTION AND TREATMENT OF NAUSEA AND VOMITING IN CHILDREN AND ADOLESCENTS RECEIVING HIGHLY EMETOGENIC CHEMOTHERAPY | 2023 |
|
RU2818947C1 |
| (R)-5-BROMO-N-ETHYL-4-METHYLHEXAHYDRO-1H-1,4-DIAZEPIN-6- YL)-2-METHOXY-6 METHYLAMINO-3-PYRIDINECARBOXAMIDE, METHOD OF PREPARATION THEREOF, PHARMACEUTICAL COMPOSITION AND ANTIEMETIC AGENT COMPRISING SAID COMPOUNDS, AND INTERMEDIATE COMPOUND THEREOF | 1996 |
|
RU2156248C2 |
